Your next opportunity to submit an outline application is now September 29, 2025, as the spring deadlines have been removed and a new September 2026 cycle has been added. When preparing your submission, please note the newly specified word limits (2,500 words for outlines) and the requirement of narrative CVs for all co-investigators requesting salary. Additionally, keep in mind that projects focused solely on biomarker validation, early detection, or prevention are now explicitly excluded from this funding.
Funder: Cancer Research UK
Due Dates: September 29, 2025 (Outline) | January 12, 2026 (Full) | April 2, 2026 (Outline) | June 25, 2026 (Full) | September 29, 2026 (Outline)
Funding Amounts: Up to £2.5 million over 5 years; funds postdocs, technical staff, PhD students, and research costs.
Summary: Supports established researchers in the UK to lead ambitious, multidisciplinary programmes in fundamental and early translational cancer research.
Key Information: Outline application and pre-application discussion with CRUK are required before full submission.